JP2016006053A5 - - Google Patents

Download PDF

Info

Publication number
JP2016006053A5
JP2016006053A5 JP2015134747A JP2015134747A JP2016006053A5 JP 2016006053 A5 JP2016006053 A5 JP 2016006053A5 JP 2015134747 A JP2015134747 A JP 2015134747A JP 2015134747 A JP2015134747 A JP 2015134747A JP 2016006053 A5 JP2016006053 A5 JP 2016006053A5
Authority
JP
Japan
Prior art keywords
virus
pharmaceutical composition
composition according
rotavirus
coronavirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015134747A
Other languages
English (en)
Japanese (ja)
Other versions
JP6193922B2 (ja
JP2016006053A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016006053A publication Critical patent/JP2016006053A/ja
Publication of JP2016006053A5 publication Critical patent/JP2016006053A5/ja
Application granted granted Critical
Publication of JP6193922B2 publication Critical patent/JP6193922B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015134747A 2009-05-12 2015-07-03 ハロアルキルヘテロアリールベンズアミド化合物 Expired - Fee Related JP6193922B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17762609P 2009-05-12 2009-05-12
US61/177,626 2009-05-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012510917A Division JP5918124B2 (ja) 2009-05-12 2010-05-11 ハロアルキルヘテロアリールベンズアミド化合物

Publications (3)

Publication Number Publication Date
JP2016006053A JP2016006053A (ja) 2016-01-14
JP2016006053A5 true JP2016006053A5 (enExample) 2016-06-09
JP6193922B2 JP6193922B2 (ja) 2017-09-06

Family

ID=43069021

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012510917A Active JP5918124B2 (ja) 2009-05-12 2010-05-11 ハロアルキルヘテロアリールベンズアミド化合物
JP2015134747A Expired - Fee Related JP6193922B2 (ja) 2009-05-12 2015-07-03 ハロアルキルヘテロアリールベンズアミド化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012510917A Active JP5918124B2 (ja) 2009-05-12 2010-05-11 ハロアルキルヘテロアリールベンズアミド化合物

Country Status (24)

Country Link
US (4) US8846727B2 (enExample)
EP (2) EP2429986B1 (enExample)
JP (2) JP5918124B2 (enExample)
KR (1) KR101760956B1 (enExample)
CN (2) CN105853415A (enExample)
AP (1) AP3074A (enExample)
AU (2) AU2010247816B2 (enExample)
BR (1) BRPI1010547A2 (enExample)
CA (2) CA2761876C (enExample)
CL (1) CL2011002830A1 (enExample)
CO (1) CO6460766A2 (enExample)
CR (1) CR20110607A (enExample)
DO (1) DOP2011000353A (enExample)
EA (1) EA021587B1 (enExample)
EC (1) ECSP11011511A (enExample)
HK (1) HK1223819A1 (enExample)
HN (1) HN2011003002A (enExample)
IL (2) IL216331B (enExample)
MX (1) MX337460B (enExample)
NI (1) NI201100199A (enExample)
NZ (1) NZ596538A (enExample)
PE (1) PE20121118A1 (enExample)
SG (2) SG176045A1 (enExample)
WO (1) WO2010132404A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2839425B2 (ja) 1993-04-14 1998-12-16 新日本製鐵株式会社 ドッグボーン型粗形鋼片の製造方法
EA021587B1 (ru) 2009-05-12 2015-07-30 РОМАРК ЛЭБОРЕТЕРИЗ Эл. Си. Соединения галогеналкилгетероарилбензамида
EA030679B1 (ru) * 2009-06-26 2018-09-28 РОМАРК ЛЭБОРЕТЕРИЗ Эл.Си. Соединения и способы лечения гриппа
HRP20161113T1 (hr) * 2011-03-22 2016-12-02 Bayer Intellectual Property Gmbh N-(1,3,4-oksadiazol-2-il)arilkarboksamidi i njihova uporaba kao herbicida
EP2739611B1 (de) * 2011-08-03 2015-05-13 Bayer Intellectual Property GmbH N-(tetrazol-5-yl)- und n-(triazol-5-yl)arylcarbonsäureamide und ihre verwendung als herbizide
ES2882807T3 (es) 2011-09-16 2021-12-02 Novartis Ag Heterociclil carboxamidas N-sustituidas
CN104854104B (zh) * 2012-12-06 2017-11-21 拜尔农作物科学股份公司 N‑(噁唑‑2‑基)‑芳基‑羧酸酰胺及其作为除草剂的用途
US9938236B2 (en) * 2012-12-27 2018-04-10 Drexel University Antiviral agents against HBV infection
JP6371077B2 (ja) * 2014-02-25 2018-08-08 国立大学法人佐賀大学 ジフルオロメチル基含有化合物及びその用途
EP3140298A1 (en) 2014-05-07 2017-03-15 Pfizer Inc. Tropomyosin-related kinase inhibitors
BR112017009651A2 (pt) 2014-11-11 2017-12-19 Romark Laboratories Lc composto, composição farmacêutica, e, método para tratamento de uma infecção por protozoário intracelular, uma infecção viral ou um câncer.
EP3227284B1 (en) 2014-12-01 2021-04-28 Syngenta Participations AG Pesticidally active amide heterocyclic derivatives with sulphur containing substituents
MX384836B (es) 2016-03-07 2025-03-14 Enanta Pharm Inc Agentes antivirales contra la hepatitis b
PT3436074T (pt) 2016-03-31 2020-08-21 Romark Laboratories Lc Compostos tiazolida para tratamento de infeções virais
SG11201808402RA (en) 2016-04-11 2018-10-30 Genfit Methods of treatment for cholestatic and fibrotic diseases
BR112019012822A2 (pt) 2016-12-22 2019-11-26 Bayer Ag 1,2,4-tiadiazolilpirrolonas e 1,2,4-tiadiazolil-hidantoínas e sais das mesmas e uso das mesmas como herbicidas
US11173149B2 (en) 2017-04-18 2021-11-16 Romark Laboratories L.C. Inhibition of protein disulfide-isomerase A3
NZ762994A (en) 2017-08-28 2025-11-28 Enanta Pharm Inc Hepatitis b antiviral agents
KR20210095143A (ko) 2018-10-22 2021-07-30 어셈블리 바이오사이언시스, 인크. Hbv의 치료를 위한 5원 헤테로아릴 카르복스아미드 화합물
SG11202105007TA (en) 2018-11-21 2021-06-29 Enanta Pharm Inc Functionalized heterocycles as antiviral agents
MX2022000278A (es) * 2019-07-19 2022-02-03 Abivax Derivados de aril-n-arilo para tratar una infeccion por virus de acido ribonucleico (arn).
WO2021016543A1 (en) * 2019-07-25 2021-01-28 Romark Laboratories L.C. Antiviral combinations of thiazolide compounds
JP7386576B2 (ja) * 2019-10-02 2023-11-27 カイノス・メディスン・インコーポレイテッド N-(1h-イミダゾール-2-イル)ベンズアミド化合物および該化合物を活性成分として含む医薬組成物
EP4101449A4 (en) * 2020-01-21 2024-02-21 Academy of Military Medical Sciences Application of nitazoxanide and active form thereof, tizoxanide, in treatment of sars-cov-2 infection
CN111187215B (zh) * 2020-01-21 2023-02-24 西北农林科技大学 含氟吡唑酰胺类衍生物、制备方法及其应用
US20230241037A1 (en) * 2020-03-09 2023-08-03 1Globe Health Institute, Nanjing Cross-linked medication for treatment of coronaviral infection and method of treatment
CN113398125B (zh) 2020-03-16 2024-05-03 绍兴君科臻元医药科技有限公司 替唑尼特药物组合物及其医药用途
WO2021188414A1 (en) 2020-03-16 2021-09-23 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents
EP4182304A1 (en) 2020-07-20 2023-05-24 Romark Laboratories, L.C. Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine
JP2023538136A (ja) 2020-08-24 2023-09-06 ロマーク ラボラトリーズ,リミティド カンパニー コロナウイルスに対するチアゾリドの利用
US20230373930A1 (en) * 2020-10-09 2023-11-23 Bristol-Myers Squibb Company Aminoimidazole fpr2 agonists
US20240002332A1 (en) * 2020-11-18 2024-01-04 Wenwei HUANG Small Molecule Inhibitors of SARS-CoV-2 Infections
WO2022130406A1 (en) * 2020-12-15 2022-06-23 Cipla Limited Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease
US12146029B1 (en) 2021-02-08 2024-11-19 Futurefuel Chemical Company Polymers enhanced with hydrated sodium sulfoisophthalic acid salts
CN116003323B (zh) * 2023-02-14 2023-12-08 西北农林科技大学 含氟吡唑苯乙酰胺类衍生物及其应用

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1177206A (en) 1967-11-28 1970-01-07 Pfizer & Co C Lung Antiviral Factor
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4343945A (en) * 1979-01-23 1982-08-10 Olin Corporation 5-Benzamido-3-trichloromethyl-1,2,4-thiadiazoles and their use as herbicides, fungicides and insecticides
US4337081A (en) * 1979-01-23 1982-06-29 Olin Corporation 5-Amido-3-trihalomethyl-1,2,4-thiadiazoles and their use as herbicides
SU910628A1 (ru) 1980-04-22 1982-03-07 Гродненский государственный медицинский институт Способ получени 2-ациламинотиазолов
JPS56158703A (en) * 1980-05-10 1981-12-07 Sankyo Co Ltd Fungicide
US4416683A (en) * 1980-09-16 1983-11-22 Eli Lilly And Company Benzamides, compositions and agricultural method
MA19269A1 (fr) * 1980-09-16 1982-04-01 Lilly Co Eli Perfectionnement relatif a des derives de n-arylbenzamides .
JPS649978A (en) 1987-07-02 1989-01-13 Shionogi & Co Perfluoroalkylisoxazole derivative
US4874864A (en) 1988-05-24 1989-10-17 Pfizer Inc. Benzamide protease inhibitors
US5169846A (en) 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
ES2222455T3 (es) 1994-01-28 2005-02-01 University Of Kentucky Research Foundation Cofarmacos como un metodo de liberacion controlada de farmacos.
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives
DK0755386T3 (da) 1994-04-13 2002-08-26 Romark Lab Lc Benzamid-derivater, sammensætninger indeholdende nævnte derivat og anvendelse deraf
US5968961A (en) 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
MX9604483A (es) * 1994-09-08 1998-02-28 Jean-Francois Rossignol Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
AU740022B2 (en) * 1997-05-07 2001-10-25 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
GB9725298D0 (en) 1997-11-28 1998-01-28 Zeneca Ltd Insecticidal thiazole derivatives
WO2000002851A1 (en) 1998-07-08 2000-01-20 Aventis Pharma Deutschland Gmbh Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
GB9823871D0 (en) 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
US6849254B1 (en) * 1999-04-19 2005-02-01 Schering Corporation HCV combination therapy
US6136835A (en) * 1999-05-17 2000-10-24 The Procter & Gamble Company Methods of treatment for viral infections
HUP0303538A2 (hu) * 2000-12-21 2005-02-28 Bristol-Myers Squibb Co. Tirozin kinázok Tec családjának tiazolil-vegyület inhibitorai és ezeket tartalmazó gyógyszerkészítmények
ATE315555T1 (de) * 2001-05-11 2006-02-15 Pfizer Prod Inc Thiazolderivate und ihre verwendung als cdk- inhibitoren
WO2002092584A1 (en) * 2001-05-14 2002-11-21 Nihon Nohyaku Co., Ltd. Thiadiazole derivatives, pesticides for agricultural and horticultural use and usage thereof
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
JP2003335680A (ja) 2002-05-21 2003-11-25 Otsuka Pharmaceut Factory Inc Acat−1阻害剤
CN101103977A (zh) * 2002-06-05 2008-01-16 株式会社医药分子设计研究所 糖尿病治疗药
US20040242518A1 (en) * 2002-09-28 2004-12-02 Massachusetts Institute Of Technology Influenza therapeutic
AU2003279004B2 (en) 2002-09-28 2009-10-08 Massachusetts Institute Of Technology Influenza therapeutic
US6737382B1 (en) * 2002-10-23 2004-05-18 Nippon Soda Co. Ltd. Insecticidal aminothiazole derivatives
US7807174B2 (en) 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
MXPA05009059A (es) * 2003-02-26 2005-10-19 Banyu Pharma Co Ltd Derivados de heteroarilcarbamoilbenceno.
US7285576B2 (en) 2003-03-12 2007-10-23 3M Innovative Properties Co. Absorbent polymer compositions, medical articles, and methods
BRPI0408815A (pt) * 2003-03-28 2006-04-04 Pharmacia & Upjohn Co Llc moduladores alostéricos positivos do receptor nicotìnico da acetilcolina
JPWO2005007151A1 (ja) * 2003-07-16 2006-08-31 株式会社医薬分子設計研究所 皮膚色素沈着の治療剤
US20050090506A1 (en) * 2003-10-24 2005-04-28 Nippon Soda Co., Ltd. Insecticidal perfluoroalkylthiazole derivatives
US7683097B2 (en) * 2004-05-27 2010-03-23 Propharmacon Inc. Topoisomerase inhibitors
UA90864C2 (en) * 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
US20060194853A1 (en) 2004-10-08 2006-08-31 Rossignol Jean F Alkyl benzamides
US8357664B2 (en) * 2004-10-26 2013-01-22 Avi Biopharma, Inc. Antisense antiviral compound and method for treating influenza viral infection
EP2047850A3 (en) * 2005-04-12 2009-07-29 Romark Laboratories, L.C. Methods for treating diseases through inhibition of the function of molecular chaperones such as protein disulfide isomerases , pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
KR20080019213A (ko) 2005-05-09 2008-03-03 아칠리온 파르마세우티칼스 인코포레이티드 티아졸 화합물 및 그 사용방법
EP2029138A1 (en) * 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
TW200711649A (en) * 2005-06-17 2007-04-01 Combinatorx Inc Combination therapy for the treatment of immunoinflammatory disorders
MX2008000141A (es) * 2005-06-27 2008-04-07 Exelixis Inc Moduladores de lxr basados en imidazol.
WO2007008541A2 (en) 2005-07-08 2007-01-18 Kalypsys, Inc. Cellular cholesterol absorption modifiers
MX2008001605A (es) 2005-08-02 2008-04-14 Irm Llc Compuestos y composiciones de tiazol-2-il amino 5-substituido como inhibidores de cinasa proteica.
RU2441869C2 (ru) 2005-12-21 2012-02-10 Эбботт Лэборетриз Противовирусные соединения
CA2636527C (en) * 2006-01-09 2016-05-17 Romark Laboratories, L.C. Viral hepatitis treatment
JP2009535318A (ja) * 2006-04-28 2009-10-01 トランステック ファーマ,インコーポレイティド ベンズアミドグルコキナーゼ活性化剤
CN101454302A (zh) * 2006-05-31 2009-06-10 艾博特公司 用作大麻素受体配位体的噻唑化合物及其用途
BRPI0712795A2 (pt) * 2006-07-07 2012-09-04 Boehringer Ingelheim Int derivados de heteroarila substituìdos com fenila e uso dos mesmos como agentes antitumorais
WO2008033466A2 (en) 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases
WO2008070707A1 (en) * 2006-12-05 2008-06-12 Smithkline Beecham Corporation Il-8 receptor antagonists
WO2009001214A2 (en) * 2007-06-28 2008-12-31 Pfizer Products Inc. Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists
BRPI0815057B8 (pt) * 2007-08-03 2021-05-25 Romark Laboratories Lc composto, composição farmacêutica, e, uso de um composto
WO2009065096A1 (en) * 2007-11-16 2009-05-22 University Of Medicine And Dentistry Of New Jersey Mechanism-based small-molecule parasite inhibitors
US20100009970A1 (en) * 2008-03-19 2010-01-14 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20100081713A1 (en) * 2008-03-19 2010-04-01 CombinatoRx, (Singapore) Pte. Ltd. Compositions and methods for treating viral infections
EA201001847A1 (ru) * 2008-06-11 2011-08-30 Айрм Ллк Соединения и композиции, применяемые для лечения малярии
TW201014860A (en) * 2008-09-08 2010-04-16 Boehringer Ingelheim Int New chemical compounds
UY32138A (es) * 2008-09-25 2010-04-30 Boehringer Ingelheim Int Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables
EP2346853A2 (en) * 2008-11-19 2011-07-27 Schering Corporation Inhibitors of diacylglycerol acyltransferase
EP2408770B1 (en) 2009-03-20 2014-11-05 University Of Virginia Patent Foundation Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
EA021587B1 (ru) * 2009-05-12 2015-07-30 РОМАРК ЛЭБОРЕТЕРИЗ Эл. Си. Соединения галогеналкилгетероарилбензамида
EA030679B1 (ru) 2009-06-26 2018-09-28 РОМАРК ЛЭБОРЕТЕРИЗ Эл.Си. Соединения и способы лечения гриппа

Similar Documents

Publication Publication Date Title
JP2016006053A5 (enExample)
MX2022009352A (es) Sal de hemisulfato de nucleotido para el tratamiento del virus de hepatitis c.
CL2017001798A1 (es) Compuestos de pirazina para el tratamiento de enfermedades infecciosas.
IL289655B1 (en) Compounds useful for treating influenza virus infections
EA202190602A2 (ru) 2'-замещенные-n6-замещенные пуриновые нуклеотиды для лечения вызванных рнк-вирусом заболеваний
LT3347352T (lt) Terapiniai junginiai, naudotini živ viruso infekcijos profilaktikai arba terapiniam gydymui
JP2017186358A5 (enExample)
PH12017501598B1 (en) ß-D-2`-DEOXY-2`a-FLUORO-2`-ß-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
EA201891876A1 (ru) Тетрациклические пиридоновые соединения в качестве противовирусных средств
WO2014134566A3 (en) Amide compounds for the treatment of hiv
HUE052856T2 (hu) Eljárások és gyógyászati készítmények Hepatitis B vírus fertõzés kezelésére
CL2014000311A1 (es) Compuestos derivados de benzotiazepinas sustituidas; composicion farmaceutica que los contiene; y su uso para el tratamiento o profilaxis de la infeccion del virus sincicial respiratorio.
CL2013003360A1 (es) “compuestos derivados de 4-aril-n-[3-(sulfonimidoil)fenil]-1,3,5-triazin-2-amina sustituidos, inhibidores cdk; compuestos intermediarios, composición y combinación farmacéutica que los comprende; y su uso en el tratamiento de enfermedades hiperproliferativas, infecciosas inducidas por virus y/o cardiovasculares”. pct
CL2011002830A1 (es) Compuestos derivados de haloalquil heteroaril benzamidas; composicion farmaceutica uso de la composicion en el tratamiento de una infeccion viral, tal como el virus de la hepatitis b y c.
ZA202006656B (en) Antiviral immunotropic agent for the treatment of acute respiratory viral infections
LT3436074T (lt) Tiazolido junginiai, skirti virusinių infekcijų gydymui
HUE045906T2 (hu) Új szulfonimidoilpurinon vegyületek és származékok vírusfertõzés kezelésére és megelõzésére
EA201490213A1 (ru) Бензофурановые соединения для лечения инфекций вирусом гепатита с
EA201691694A1 (ru) Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк- и/или днк-содержащими вирусами, и сопутствующих заболеваний
CL2014000394A1 (es) Uso de compuestos fenil-benzofuran-sulfamido sustituidos para el tratamiento del virus de la hepatitis c (hcv); y composicion farmaceutica que comprende a estos compuestos fenil-benzofuran-sulfamido sustituidos.
HUE071451T2 (hu) Vegyület, gyógyászatilag elfogadható sója vagy optikai izomere, eljárás elõállítására és hatóanyagként azt tartalmazó, vírusos betegség megelõzésére vagy kezelésére szolgáló gyógyászati készítmény
CY1118920T1 (el) Ενωσεις πιπεραζινης- πιπεριδινης ως αναστολεις του ιου ηπατιτιδας c
EP3995149A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLUENCE VIRUS INFECTIONS
EA202092602A2 (ru) -d-2'-дезокси-2'--фтор-2'--c-замещенные-2-модифицированные-n6-замещенные пуриновые нуклеотиды для лечения вызванных hcv заболеваний
EA201991810A1 (ru) Гемисульфатная соль нуклеотида для лечения вируса гепатита с